Yazılar

Nvidia Completes $700 Million Acquisition of Run:ai After Regulatory Scrutiny

/in /tarafından

Nvidia has successfully completed its $700 million acquisition of Israeli AI startup Run:ai, following regulatory scrutiny from antitrust authorities. The European Commission granted unconditional approval for the deal earlier in December, after initially flagging concerns about potential competition issues. The acquisition, which had been under investigation due to Nvidia’s dominant position in the graphics processing unit (GPU) market, was cleared after the Commission determined it would not hinder competition. The U.S. Department of Justice is also reviewing the deal on antitrust grounds. Run:ai, known for its AI infrastructure optimization tools, announced plans to make its software open-source, extending its compatibility beyond Nvidia’s GPUs to support the broader AI ecosystem.

 

Elon Musk Announces Starlink Inactive in India After Device Seizures

/in /tarafından

Elon Musk confirmed on Tuesday that Starlink satellite internet is inactive in India, marking the company’s first public acknowledgment since Indian authorities seized two Starlink devices in recent weeks. One device was found in Manipur, an area in northeastern India suffering from ongoing communal conflict, and the other was discovered during a drug smuggling bust at sea.

Starlink, the satellite internet service owned by Musk’s SpaceX, is seeking approval from Indian authorities to offer satellite broadband services in the country. The company is working to address security concerns as part of the approval process. In his post on X (formerly Twitter), Musk clarified that “Starlink satellite beams are turned off over India” and that the service had “never been on in the first place.”

Musk’s comments came after the Indian Army shared photos on December 13 of a search operation in Manipur, which included images of a Starlink device along with seized weapons. According to two military officers who requested anonymity, the device was being used by a militant group. The officers suggested that the device had likely been smuggled into India through its porous border with Myanmar, where Starlink devices have been reportedly used by rebel groups, although the company does not operate in Myanmar.

Earlier in December, Indian police made a legal request to Starlink for details on the purchase of a Starlink device found during a large drug bust at sea. Authorities believe the smugglers used the device to help with navigation while transporting $4.2 billion worth of methamphetamine, one of India’s largest-ever drug seizures.

 

Regulatory Conditions Cleared for Novo Holdings’ $16.5 Billion Catalent Acquisition

/in /tarafından

Novo Holdings announced on Saturday that all regulatory conditions for its $16.5 billion acquisition of U.S. contract drug manufacturer Catalent have been fulfilled. The companies anticipate completing the transaction in the coming days.

The acquisition, initially agreed upon in February, is part of Novo Holdings’ strategy to increase production of the blockbuster weight-loss drug Wegovy, developed by its affiliate Novo Nordisk. As part of the agreement, Novo Holdings will sell three of Catalent’s factories located in Italy, Belgium, and the United States to Novo Nordisk for $11 billion. These facilities specialize in filling injection pens under sterile conditions.

Novo Holdings is the controlling shareholder of Novo Nordisk, the Danish pharmaceutical giant behind the popular GLP-1 injectable drug Wegovy. Novo Nordisk stated that while the acquisition aligns with its strategic goals, it is expected to have a mid single-digit negative impact on operating profit growth in 2025. Consequently, the company does not plan to initiate a share buyback program for the year.

Regulatory and Antitrust Scrutiny

The deal has faced close regulatory scrutiny. Earlier in December, the European Commission granted EU antitrust approval, stating that the merger posed no competition concerns within the European Economic Area (EEA).

In the United States, the acquisition drew criticism from consumer groups, labor unions, and policymakers. U.S. Senator Elizabeth Warren urged the Federal Trade Commission (FTC) to scrutinize the deal, citing potential concerns. The FTC had requested additional information on the acquisition in May, but no further updates have been issued.

Strategic Implications

The transaction underscores Novo Holdings’ commitment to expanding its role in the manufacturing and distribution of high-demand pharmaceuticals. By integrating Catalent’s production capabilities, Novo Holdings aims to meet the growing demand for weight-loss treatments while maintaining compliance with global competition regulations.